Abstract
Aims: To improve the care of children who are victims of child sexual abuse (CSA) by routinely assessing eligibility for HIV post-exposure prophylaxis (PEP) and to investigate the feasibility, safety, and efficacy of such treatment started in a paediatric emergency department in Malawi.
Methods: Children presenting to the Queen Elizabeth Central Hospital, Blantyre between 1 January 2004 and 31 December 2004 with a history of alleged CSA were assessed for eligibility for HIV PEP and followed prospectively for six months.
Results: A total of 64 children presented with a history of alleged CSA in the 12 month period; 17 were offered PEP. The remainder were not offered PEP because of absence of physical signs of abuse (n = 20), delay in presentation beyond 72 hours from assault (n = 11), repeated sexual abuse in the preceding six months (n = 15), and HIV infection found on initial testing (n = 1). No family refused an HIV test. No side effects due to antiretroviral therapy were reported. Of the 17 children commenced on PEP, 11 returned for review after one month, seven returned at three months, and two of 15 returned at six months post-assault. None have seroconverted.
Conclusions: In a resource-poor setting with a high HIV prevalence, HIV PEP following CSA is acceptable, safe, and feasible. HIV PEP should be incorporated in to national guidelines in countries with a high community prevalence of HIV infection.
Full Text
The Full Text of this article is available as a PDF (68.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Almeda J., Casabona J., Simon B., Gerard M., Rey D., Puro V., Thomas T., Euro-NONOPEP Project group Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveill. 2004 Jun;9(6):35–40. [PubMed] [Google Scholar]
- Angyo I. A., Okpeh E. S., Onah J. Paediatric AIDS in Jos, Nigeria. West Afr J Med. 1998 Oct-Dec;17(4):268–272. [PubMed] [Google Scholar]
- Babl F. E., Cooper E. R., Damon B., Louie T., Kharasch S., Harris J. A. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med. 2000 May;18(3):282–287. doi: 10.1016/s0735-6757(00)90123-2. [DOI] [PubMed] [Google Scholar]
- Cardo D. M., Culver D. H., Ciesielski C. A., Srivastava P. U., Marcus R., Abiteboul D., Heptonstall J., Ippolito G., Lot F., McKibben P. S. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997 Nov 20;337(21):1485–1490. doi: 10.1056/NEJM199711203372101. [DOI] [PubMed] [Google Scholar]
- Giele C. M., Maw R., Carne C. A., Evans B. G., British Co-operative Clinical Group of the Medical Society for the Study of Venereal Diseases Post-exposure prophylaxis for non-occupational exposure to HIV: current clinical practice and opinions in the UK. Sex Transm Infect. 2002 Apr;78(2):130–132. doi: 10.1136/sti.78.2.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gray R. H., Wawer M. J., Brookmeyer R., Sewankambo N. K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., vanCott T., Quinn T. C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001 Apr 14;357(9263):1149–1153. doi: 10.1016/S0140-6736(00)04331-2. [DOI] [PubMed] [Google Scholar]
- Gutman L. T., Herman-Giddens M. E., McKinney R. E., Jr Pediatric acquired immunodeficiency syndrome. Barriers to recognizing the role of child sexual abuse. Am J Dis Child. 1993 Jul;147(7):775–780. doi: 10.1001/archpedi.1993.02160310077023. [DOI] [PubMed] [Google Scholar]
- Havens Peter L., American Academy of Pediatrics Committee on Pediatric AIDS Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics. 2003 Jun;111(6 Pt 1):1475–1489. doi: 10.1542/peds.111.6.1475. [DOI] [PubMed] [Google Scholar]
- Kahn J. O., Martin J. N., Roland M. E., Bamberger J. D., Chesney M., Chambers D., Franses K., Coates T. J., Katz M. H. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J Infect Dis. 2001 Feb 1;183(5):707–714. doi: 10.1086/318829. [DOI] [PubMed] [Google Scholar]
- Limb S., Kawsar M., Forster G. E. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS. 2002 Sep;13(9):602–605. doi: 10.1258/09564620260216290. [DOI] [PubMed] [Google Scholar]
- Menick D. Mbassa, Ngoh F. Séro-prévalence de l'infection à VIH chez les enfants victimes d'abus sexuels au Cameroun. Med Trop (Mars) 2003;63(2):155–158. [PubMed] [Google Scholar]
- Pitché P., Kombaté K., Gbadoé A. D., Tchangaï-Walla K. Les maladies sexuellement transmissibles chez le jeune enfant à Lomé (Togo). Place de l'abus sexuel. Arch Pediatr. 2001 Jan;8(1):25–31. doi: 10.1016/s0929-693x(00)00162-7. [DOI] [PubMed] [Google Scholar]
- Thomas A., Forster G., Robinson A., Rogstad K., Clinical Effectiveness Group Association of Genitourinary Medicine. Medical Society for the Study of Venereal Diseases National guideline for the management of suspected sexually transmitted infections in children and young people. Arch Dis Child. 2003 Apr;88(4):303–311. doi: 10.1136/adc.88.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiebe E. R., Comay S. E., McGregor M., Ducceschi S. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. CMAJ. 2000 Mar 7;162(5):641–645. [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.